Role of pancreatic β-cell death and inflammation in diabetes

Diabetes, Obesity and Metabolism

Volumn 15, Issue S3, 2013, Pages 141-151

  Quan, W ^a   Jo, E K ^b   Lee, M S ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Autophagy; Cell death; Inflammasomes; Inflammation; cells

Indexed keywords

AMYLIN; STRESS ACTIVATED PROTEIN KINASE;

ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOPHAGY; CELL DEATH; CELLS; DIABETES MELLITUS; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INFLAMMATION; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ONTOGENY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL HYPERPLASIA; REVIEW;

AUTOPHAGY; CELL DEATH; INFLAMMASOMES; INFLAMMATION; Β-CELLS;

ANIMALS; APOPTOSIS; AUTOPHAGY; CELL DEATH; DIABETES MELLITUS; HUMANS; INFLAMMASOMES; INFLAMMATION; INSULIN-SECRETING CELLS;

EID: 84883546693     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12153     Document Type: Review

References (114)

1. Kim S, Millet I, Kim HS et al. NF-κB prevents β cell death and autoimmune diabetes in NOD mice. Proc Natl Acad Sci U S A 2007; 104: 1913-1918.
2. Kurrer MO, Pakala SV, Hanson HL, Katz JD. β Cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci U S A 1997; 94: 213-218.
3. Wang Y, Pontesilli O, Gill RD, La Rosa FG, Lafferty KJ. The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc Natl Acad Sci U S A 1991; 88: 527-531.
4. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. β-Cell deficit and increased β-cell apoptosis in human with type 2 diabetes. Diabetes 2003; 52: 102-110.
5. Yoon KH, Ko SH, Cho JH et al. Selective β-cell loss and α-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 2003; 88: 2300-2308.
6. Higa M, Zhou Y-T, Ravazzola M, Baetens D, Orci L, Unger RH. Troglitazone prevents mitochondrial alterations, β cell destruction, and diabetes in obese prediabetic rats. Proc Natl Acad Sci U S A 1999; 96: 11513-11518.
7. Kaneto H, Kajimoto Y, Miyazaki J-I et al. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic β-cells against glucose toxicity. Diabetes 1999; 48: 2398-2406.
8. Donath MY, Gross DJ, Carasi E, Kaiser N. Hyperglycemia-induced β-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 1999; 48: 738-744.
9. Talchai C, Xuan S, Lin HV, Sussel L, Accili D. Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell 2012; 150: 1223-1234.
10. Trudeau JD, Dutz JP, Arany E, Hill DJ, Fieldus WE, Finegood DT. Neonatal β-cell apoptosis: a trigger for autoimmune diabetes? Diabetes 2000; 49: 1-7.
11. Choi CS, Befroy DE, Codella R et al. Paradoxical effects of increased expression of PGC-1α on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism. Proc Natl Acad Sci U S A 2007; 105: 19926-19931.
12. Kroemer G, Marino G, Levine B. Autophagy and the integrated stress response. Mol Cell 2010; 40: 280-293.
13. Ebato C, Uchida T, Arakawa M et al. Autophagy is important in islet homeostasis and compensatory increase of β cell mass in response to high-fat diet. Cell Metab 2008; 8: 325-332.
14. Jung HS, Chung KW, Kim JW et al. Loss of autophagy diminishes pancreatic β-cell mass and function with resultant hyperglycemia. Cell Metab 2008; 8: 318-324.
15. Degenhardt K, Mathew R, Beaudoin B et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006; 10: 51-64.
16. Michaud M, Martins I, Sukkurwala AQ et al. Autophagy-dependent anticancer immune responses iduced by chemotherapeutic agents in mice. Science 2011; 334: 1573-1577.
17. Mathis D, Benoist C. Levees of immunological tolerance. Nat Immunol 2010; 11: 3-6.
18. Katz JD, Benoist C, Mathis D. T helper cell subset in insulin-dependent diabetes. Science 1995; 268: 1185-1188.
19. Cha S-S, Kim M-S, Choi YH et al. 2.8 A resolution crystal structure of human TRAIL, a cytokine with selective tumor activity. Immunity 1999; 11: 253-261.
20. Choi SE, Lee SM, Lee YJ et al. Protective role of autophagy in palmitate-induced INS-1 β cell death. Endocrinology 2009; 150: 126-134.
21. Turley S, Poirot L, Hattori M, Benoist C, Mathis D. Physiological β cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J Exp Med 2003; 198: 1527-1537.
22. Chervonsky AV, Wang Y, Wong FS et al. The role of Fas in autoimmune diabetes. Cell 1997; 89: 17-24.
23. Baek S-H, Kwon TK, Kim J-H et al. Secretory phospholipase A2-potentiated inducible nitric oxide synthase expression by macrophage requires NF-kB activation. J Immunol 2000; 164: 6359-6365.
24. Apostolou I, Hao Z, Rajewsky K, von Boehmer H. Effective destruction of Fas-deficient insulin-producing b cells in type 1 diabetes. J Exp Med 2003; 198: 1103-1106.
25. Lee J, Hur J, Lee P et al. Dual role of inflammatory stimuli in activation-induced cell death of mouse microglial cells. J Biol Chem 2001; 276: 32956-32965.
26. Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005; 54: S97-107.
27. Jones BE, Lo CR, Liu H et al. Hepatocytes sensitized to tumor necrosis factor-a cytotoxicity undergo apoptosis through caspase-dependent and caspase-independent pathways. J Biol Chem 2000; 275: 705-712.
28. Santin I, Moore F, Grieco FA, Marchetti P, Brancolini C, Eizirik DL. USP18 is a key regulator of the interferon-driven gene network modulating pancreatic β cell inflammation and apoptosis. Cell Death Dis 2012; 3: e419.
29. Gysemans CA, Ladriere L, Callewaert H et al. Disruption of the γ-interferon signaling pathway at the level of signal transducer and activator of transcription-1 prevents immune destruction of β-cells. Diabetes 2005; 54: 2396-2403.
30. Beg AA, Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 1996; 274: 782-784.
31. Giannoukakis N. DiaPep277. Curr Opin Investig Drugs 2005; 6: 1043-1050.
32. Gurzov EN, Germano CM, Cunha DA et al. p53 up-regulated modulator of apoptosis (PUMA) activation conributes to pancreatic β-cell apoptosis induced by proinflammatory cytokines and endoplasmic reticulum stress. J Biol Chem 2010; 26: 19910-19920.
33. Gurzov EN, Ortis F, Cunha DA, Gosset G, Cardozo AK, Eizirik DL. Signaling by IL-1β+IFN-γ and ER stress converge on DP5/Hrk activation: a novel mechanism for pancreatic β-cell apoptosis. Cell Death Differ 2009; 16: 1539-1550.
34. Finegood DT, MaArthur MD, Kojwang D et al. β-Cell mass dynamics in Zucker Diabetic Fatty rats. Diabetes 2001; 50: 1021-1029.
35. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B. β-Cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 2000; 49: 1325-1333.
36. Briaud I, Harmon JS, Kelpe CL, Segu VBG, Poitout V. Lipotoxicity of the pancreatic β-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. Diabetes 2001; 50: 315-321.
37. Beg AA. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol 2002; 23: 509-512.
38. Yamada K, Moriyama H, Okumachi Y et al. Intravenous administration of proinsulin 1 or 2-expressing fiber-mutant recombinant adenovirus vector protects against the development of diabetes in NOD mice. Ann N Y Acad Sci 2008; 1150: 183-186.
39. Heikenwalder M, Polymenidou M, Junt T et al. Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med 2004; 10: 187-192.
40. Oyadomari S, Takeda K, Takiguchi M et al. Nitric oxide-induced apoptosis in pancreatic β cells is mediated by the endoplasmic reticulum stress pathway. Proc Natl Acad Sci U S A 2001; 98: 10845-10850.
41. Kim DH, Lee J-C, Kim S et al. Inhibition of autoimmune diabetes by TLR2 tolerance. J Immunol 2011; 187: 5211-5220.
42. Mu J, Woods J, Zhou YP et al. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic β-cell mass and function in a rodent model of type 2 diabetes. Diabetes 2006; 55: 1695-1704.
43. Kim DH, Lee J-C, Lee M-K, Kim K-W, Lee M-S. Treatment of autoimmune diabetes by toll-like receptor 2 tolerance in conjunction with dipeptidyl peptidase 4 inhibition. Diabetologia 2012; 55: 3308-3317.
44. Diana J, Simoni Y, Furio L et al. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med 2013; 19: 65-73.
45. Kim S-J, Nian C, Doudet DJ, McIntosh CH. Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation. Diabetes 2009; 58: 641-651.
46. Suarez-Pinzon WL, Cembrowski GS, Rabinovitch A. Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycemia in non-obese diabetic mice. Diabetologia 2009; 52: 1680-1682.
47. Tian L, Gao J, Hao J et al. Reversal of new-onset diabetes through modulating inflammation and stimulating β-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor. Endocrinology 2010; 151: 3049-3060.
48. Reinhold D, Goihl A, Wrenger S et al. Role of dipeptidyl peptidase IV (DPPIV)-like enzymes in T lymphocyte activation: investigations in DPPIV/CD26-knockout mice. Clin Chem Lab Med 2009; 47: 268-274.
49. Vora KA, Porter G, Peng R et al. Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses. BMC Immunol 2009; 10: 1-11.
50. Ellis SL, Moser EG, Snell-Bergeon JK, Rodionova AS, Hazenfield RM, Garg SK. Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial. Diabet Med 2011; 28: 1176-1181.
51. Kielgast U, Holst JJ, Madsbad S. Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and withou residual β-cell function. Diabetes 2011; 60: 1599-1607.
52. Kahn SE. The relative contribution of insulin resistance and β-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003; 46: 3-19.
53. Haller MJ, Viener HL, Wasserfall C, Brusko T, Atkinson MA, Schatz DA. Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol 2008; 36: 710-715.
54. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11: 98-107.
55. Chakir H, Lefebvre DE, Wang H, Caraher E, Scott FW. Wheat protein-induced proinflammatory T helper 1 bias in mesenteric lymph nodes of young diabetes-prone rats. Diabetologia 2005; 48: 1576-1584.
56. Roden M, Price TB, Perseghin G et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996; 97: 2859-2865.
57. Cheng J, Zhou T, Liu C et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263: 1759-1762.
58. Shimabukuro M, Wang MY, Zhou YT, Newgard CB, Unger RH. Protection against lipoapoptosis of β cells through leptin-dependent maintenance of Bcl-2 expression. Proc Natl Acad Sci U S A 1998; 95: 9558-9561.
59. Maedler K, Spinas GA, Dyntar D, Moritz W, Kaiser N, Donath MY. Distinct effects of saturated and monounsaturated fatty acids on β-cell turnover and function. Diabetes 2001; 50: 69-76.
60. Paumen MB, Ishida Y, Muramatsu M, Yamamoto M, Honjo T. Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. J Biol Chem 1997; 272: 3324-3329.
61. Couri CE, Oliveira MC, Stracieri AB et al. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2009; 301: 1573-1579.
62. Solinas G, Naugler W, Galimi F, Lee M-S, Karin M. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc Natl Acad Sci U S A 2006; 103: 16454-16459.
63. Holtzer RG, Park E-J, Li N et al. Saturated fatty acids induce c-Src clustering within membrane subdomains, leading to JNK activation. Cell 2011; 147: 173-184.
64. Koves TR, Ussher JR, Noland RC et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008; 7: 45-56.
65. Montell E, Turini M, Marotta M et al. DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells. Am J Physiol 2001; 280: E229-E237.
66. Perseghin G, Scifo P, De Cobelli F et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans. Diabetes 1999; 48: 1600-1606.
67. Karroubi I, Ladrière L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL. Free fatty acids and cytokines induce pancreatic β-cell apoptosis by different mechanisms: role of nuclear factor-κB and endoplasmic reticulum stress. Endocrinology 2004; 145: 5087-5096.
68. Cunha DA, Igoillo-Esteve M, Gurzov EN et al. Death protein 5 and p53-upregulated modulator of apoptosis mediate the endoplasmic reticulum stress-mitochondrial dialog triggering lipotoxic rodent and human β-cell apoptosis. Diabetes 2012; 61: 2763-2775.
69. Upton JP, Wang L, Han D et al. IRE1α cleaves select microRNAs during ER stress to derepress translation of proapoptotic Caspase-2. Science 2012; 338: 818-822.
70. Lipson KL, Fonseca SG, Ishigaki S et al. Regulation of insulin biosynthesis in pancreatic β cells by an endoplasmic reticulum-resident protein kinase IRE1. Cell Metab 2006; 4: 245-254.
71. Lipson KL, Ghosh R, Urano F. The role of IRE-1α in the degradation of insulin mRNA in pancreatic β-cells. PLoS One 2008; 3: e1648.
72. Merksamer PI, Trusina A, Papa FR. Real-time redox measurements during endoplasmic reticulum stress reveal interlinked protein folding functions. Cell 2008; 135: 933-947.
73. Chan JY, Luzuriaga J, Bensellam M, Biden TJ, Laybutt DR. Failure of the adaptive unfolded protein response in islets of obese mice is linked with abnormalities in β-cell gene expression and progression to diabetes. Diabetes 2013; 62: 1557-1568.
74. Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and β-cell dysfunction. Endocr Rev 2008; 29: 351-366.
75. Bachar E, Ariav Y, Ketzinel-Gilad M, Cerasi E, Kaiser N, Leibowitz G. Glucose amplifies fatty acid-induced endoplasmic reticulum stress in pancreatic β-cells via activation of mTORC1. PLoS One 2009; 4: e4954.
76. Ozcan U, Cao Q, Yilmaz E et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004; 306: 457-461.
77. Ehses JA, Perren A, Eppler E et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 2007; 56: 2356-2370.
78. Lauber K, Bohn E, Krober SM et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 2003; 113: 717-730.
79. Larsen CM, Faulenbach M, Vaag A et al. Interleukin-1 receptor antagonist-treatment of patients with type 2 diabetes. Ugeskr Laeger 2007; 169: 3868-3871.
80. Böni-Schnetzler M, Thorne J, Parnaud G et al. Increased interleukin (IL)-1β messenger ribonucleic acid expression in β-cells of individuals with type 2 diabetes and regulation of IL-1β in human islets by glucose and autostimulation. J Clin Endocrinol Metab 2008; 93: 4065-4074.
81. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010; 11: 136-141.
82. Welsh N, Cnop M, Kharroubi I et al. Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets? Diabetes 2005; 54: 3238-3244.
83. Kim S, Kim HS, Chung KW et al. Essential role for STAT1 in pancreatic β-cell death and autoimmune type 1 diabetes of NOD mice. Diabetes 2007; 56: 2651-2658.
84. Larsen CM, Faulenbach M, Vaag A et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007; 356: 1517-1526.
85. Gallucchi S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5: 1249-1255.
86. Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140: 821-832.
87. Kuger TA, Sansonetti PJ. NLR functions beyond pathogene recognition. Nat Immunol 2011; 12: 121-128.
88. Lee M-S. Role of innate immunity in diabetes and metabolism: recent progress in the study of inflammasomes. Immune Netw 2011; 11: 95-99.
89. Kanneganti T-D, Lamkanfi M, Kim Y-G et al. Pannexin-1-mediated recognition of bacterial molecules activates the cryopirin inflammasome independent of Toll-like receptor signaling. Immunity 2007; 26: 433-443.
90. Nakahira K, Haspel JA, Rathinam VAK et al. Autophagy proteins regulates innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011; 8: 222-231.
91. Zhou R, Yazdi AS, Menu P, Tshopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011; 469: 221-226.
92. Park SW, Zhou Y, Lee J et al. The regulatory subunits of PI3K, p85α and p85β, interact with XBP-1 and increase its nuclear translocation. Nat Med 2010; 16: 429-437.
93. Masters SL, Dunne A, Subramanian SL et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol 2010; 11: 897-904.
94. Vandanmagsar B, Youm Y-H, Ravussin A et al. The NLRP3 inflammasome instigate obesity-induced inflammation and insulin resistance. Nat Med 2011; 17: 179-188.
95. Wen H, Gris D, Lei Y et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 2011; 12: 408-415.
96. Oka S, Yoshihara E, Bizen-Abe A et al. Thioredoxin binding protein-2/thioredoxin-interacting protein is a critical regulator of insulin secretion and peroxisome proliferator-activated receptor function. Endocrinology 2009; 150: 1225-1234.
97. Youm Y-H, Adijiang A, Vandanmagsar B, Burk D, Ravussin A, Dixit VM. Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage. Endocrinology 2012; 152: 4039-4045.
98. Westwell-Roper C, Dai DL, Soukhatcheva G et al. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J Immunol 2011; 187: 2755-2765.
99. Halle A, Hornung V, Petzold GC et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-β. Nat Immunol 2008; 8: 857-865.
100. Lerner AG, Upton JP, Praveen PV et al. IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab 2012; 16: 250-264.
101. Oslowski CM, Hara T, O'Sullivan-Murphy B et al. Thioredoxin-interacting protein mediates ER stress-induced β cell death through initiation of the inflammasome. Cell Metab 2012; 16: 265-273.
102. Lee H-M, Kim J-J, Kim HJ, Shong M, Ku BJ, Jo EK. Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes 2013; 62: 194-204.
103. Dasu MR, Devaraj S, Park S, Jialal I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 2010; 33: 8681-8868.
104. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290: 1717-1721.
105. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132: 27-42.
106. Komatsu M, Waguri S, Ueno T et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 2005; 169: 425-434.
107. Bernales S, McDonald KL, Walter P. Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLoS Biol 2006; 4: e423.
108. Hamasaki M, Yoshimor T. Where do they come from? Insights from autophagosome formation. FEBS Lett 2010; 584: 1296-1301.
109. Back SH, Scheuner D, Han J et al. Translation attenuation through eIF2α phosphorylation prevents oxidative stress and maintains the differentiated state in β cells. Cell Metab 2009; 10: 13-26.
110. Quan W, Hur KY, Lim Y et al. Autophagy deficiency in β cells leads to compromised unfolded protein response and progression from obesity to diabetes in mice. Diabetologia 2012; 55: 392-403.
111. Scheuner D, Vander Mierde D, Song B et al. Control of mRNA translation preserves endoplasmic reticulum function in β cells and maintains glucose homeostasis. Nat Med 2005; 11: 757-764.
112. Bachar-Wikstrom E, Wikstrom JD, Ariav Y et al. Stimulation of autophagy improves endoplasmic reticulum stress-induced diabetes. Diabetes 2013; 62: 1227-1237.
113. Saitoh T, Fujita N, Jang MH et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production. Nature 2008; 456: 264-269.
114. Quan W, Lim YM, Lee M-S. Role of autophagy in diabetes and ER stress of pancreatic β-cells. Exp Mol Med 2012; 44: 81-88.